{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T12:26:34Z","timestamp":1778847994857,"version":"3.51.4"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mutation Research\/Genetic Toxicology and Environmental Mutagenesis"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.mrgentox.2016.01.008","type":"journal-article","created":{"date-parts":[[2016,3,6]],"date-time":"2016-03-06T14:45:32Z","timestamp":1457275532000},"page":"28-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Comparison of in vivo genotoxic and carcinogenic potency to augment mode of action analysis: Case study with hexavalent chromium"],"prefix":"10.1016","volume":"800-801","author":[{"given":"Chad M.","family":"Thompson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Bichteler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia E.","family":"Rager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mina","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah M.","family":"Proctor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurie C.","family":"Haws","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mrgentox.2016.01.008_bib0005","article-title":"Estimating the carcinogenic potency of chemicals from the in vivo micronucleus test","author":"Soeteman-Hernandez","year":"2015","journal-title":"Mutagenesis"},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0010","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.mrgentox.2014.10.008","article-title":"IWGT report on quantitative approaches to genotoxicity risk assessment II. Use of point-of-departure (PoD) metrics in defining acceptable exposure limits and assessing human risk","volume":"783","author":"MacGregor","year":"2015","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0015","series-title":"Estimating the Carcinogenic Potency of Chemicals from in Vivo Micronucleus Test","author":"Hernandez","year":"2012"},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0020","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/em.20651","article-title":"Can carcinogenic potency be predicted from in vivo genotoxicity data? A meta-analysis of historical data","volume":"52","author":"Hernandez","year":"2011","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0025","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/etc.34","article-title":"Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment","volume":"29","author":"Ankley","year":"2010","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jat.2949","article-title":"New developments in the evolution and application of the WHO\/IPCS framework on mode of action\/species concordance analysis","volume":"34","author":"Meek","year":"2014","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0035","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1006\/rtph.2001.1493","article-title":"IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis","volume":"34","author":"Sonich-Mullin","year":"2001","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0040","series-title":"Guidelines for Carcinogen Risk Assessment, EPA\/F, Risk Assessment Forum","author":"U.S. EPA","year":"2005"},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0045","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.yrtph.2015.10.011","article-title":"Consideration of non-linear non-threshold and threshold approaches for assessing the carcinogenicity of oral exposure to hexavalent chromium","volume":"73","author":"Haney","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0050","unstructured":"Health Canada, Chromium in Drinking Water: Document for Public Consultation (2015)."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0055","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3109\/10408444.2013.768596","article-title":"Assessment of the mode of action underlying development of rodent small intestinal tumors following oral exposure to hexavalent chromium and relevance to humans","volume":"43","author":"Thompson","year":"2013","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0060","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.yrtph.2015.04.004","article-title":"Increasing scientific confidence in adverse outcome pathways: application of tailored Bradford-Hill considerations for evaluating weight of evidence","volume":"72","author":"Becker","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0065","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/em.20525","article-title":"An evaluation of the mode of action framework for mutagenic carcinogens case study II: chromium (VI)","volume":"51","author":"McCarroll","year":"2010","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0070","unstructured":"NTP, National Toxicology Program technical report on the toxicology and carcinogenesis studies of sodium dichromate dihydrate (CAS No. 7789-12-0) in F344\/N rats and B6C3F1 mice (drinking water studies), NTP TR 546 NIH Publication No. 08-5887 (2008)."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0075","unstructured":"NTP, National Toxicology Program technical report on the toxicity studies of sodium dichromate dihydrate (CAS No. 7789-12-0) administered in drinking water to male and female F344\/N rats and B6C3F1 mice and male BALB\/c and am3-C57BL\/6 mice, NTP Toxicity Report Series Number 72, NIH Publication No. 07-5964 (2007)."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0080","unstructured":"W. Slob, R. Cotton, proast61.3: benchmark dose modelling. R package version 61.3, RIVM2013."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0085","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3109\/10408444.2013.853726","article-title":"Shape and steepness of toxicological dose-response relationships of continuous endpoints","volume":"44","author":"Slob","year":"2014","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0090","series-title":"Cancer Risk Assessment","first-page":"699","article-title":"Combining neoplasms for evaluation of rodent carcinogenesis studies","author":"Brix","year":"2010"},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0095","first-page":"283","article-title":"Guidelines for combining neoplasms for evaluation of rodent carcinogenesis studies","volume":"76","author":"McConnell","year":"1986","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0100","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1383-5718(99)00099-6","article-title":"Development of a mouse cell line containing the PhiX174 am3 allele as a target for detecting mutation","volume":"444","author":"Chen","year":"1999","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0105","first-page":"1","article-title":"NTP toxicity studies of sodium dichromate dihydrate (CAS No. 7789-12-0) administered in drinking water to male and female F344\/N rats and B6C3F1 mice and male BALB\/c and am3-C57BL\/6 mice","author":"Bucher","year":"2007","journal-title":"Toxic. Rep. Ser."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0110","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.mrgentox.2006.06.011","article-title":"Oral chromium(VI) does not affect the frequency of micronuclei in hematopoietic cells of adult mice and of transplacentally exposed fetuses","volume":"610","author":"De Flora","year":"2006","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0115","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/toxsci\/kfr164","article-title":"Investigation of the mode of action underlying the tumorigenic response induced in B6C3F1 mice exposed orally to hexavalent chromium","volume":"123","author":"Thompson","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/toxsci\/kfr280","article-title":"Comparison of the effects of hexavalent chromium in the alimentary canal of F344 rats and B6C3F1 mice following exposure in drinking water: implications for carcinogenic modes of action","volume":"125","author":"Thompson","year":"2012","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0125","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.fct.2014.01.009","article-title":"High concentrations of hexavalent chromium in drinking water alter iron homeostasis in F344 rats and B6C3F1 mice","volume":"65","author":"Suh","year":"2014","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0130","unstructured":"NCI, Bioassay of Captan for possible Carcinogenicity, CAS No. 133-06-2, National Cancer Institute CARCINOGENESIS Technical Report Series, 15 (1977)."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0135","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1289\/ehp.0800208","article-title":"Hexavalent chromium is carcinogenic to F344\/N rats and B6C3F1 mice after chronic oral exposure","volume":"117","author":"Stout","year":"2009","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0140","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/em.21952","article-title":"Assessment of the mutagenic potential of Cr(VI) in the oral mucosa of Big Blue((R)) transgenic F344 rats","volume":"56","author":"Thompson","year":"2015","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0145","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1053\/j.gastro.2011.05.007","article-title":"Mutant KRAS promotes hyperplasia and alters differentiation in the colon epithelium but does not expand the presumptive stem cell pool","volume":"141","author":"Feng","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0150","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mrgentox.2013.03.008","article-title":"Assessment of K-Ras mutant frequency and micronucleus incidence in the mouse duodenum following 90-days of exposure to Cr(VI) in drinking water","volume":"754","author":"O\u2019Brien","year":"2013","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0155","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.mrgentox.2015.05.004","article-title":"Duodenal crypt health following exposure to Cr(VI): micronucleus scoring, gamma-H2AX immunostaining, and synchrotron X-ray fluorescence microscopy","volume":"789\u2013790","author":"Thompson","year":"2015","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0160","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/toxsci\/kfu206","article-title":"Synchrotron-based imaging of chromium and gamma-H2AX immunostaining in the duodenum following repeated exposure to Cr(VI) in drinking water","volume":"143","author":"Thompson","year":"2015","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0165","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cbi.2012.08.016","article-title":"Physiologically based pharmacokinetic model for rats and mice orally exposed to chromium","volume":"200","author":"Kirman","year":"2012","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0170","unstructured":"NTP, National Toxicology Program technical report on the toxicology and carcinogenesis studies of chromium picolinate monohydrate (CAS NO. 27882-76-4) in F344\/N rats and B6C3F1 mice (feed studies), NIH Publication No. 08-5897 (2008)."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0175","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/toxsci\/kfv070","article-title":"Long-term coexposure to hexavalent chromium and B[a]P causes tissue-specific differential biological effects in liver and gastrointestinal tract of mice","volume":"146","author":"Sanchez-Martin","year":"2015","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0180","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1289\/ehp.1307539","article-title":"Standardizing benchmark dose calculations to improve science-based decisions in human health assessments","volume":"122","author":"Wignall","year":"2014","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0185","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mrgentox.2015.01.001","volume":"780\u2013781","author":"Hamada","year":"2015","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0190","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/mutage\/geq066","article-title":"Micronucleus assays in rodent tissues other than bone marrow","volume":"26","author":"Morita","year":"2011","journal-title":"Mutagenesis"},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0195","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.mrgentox.2015.03.001","article-title":"Micronucleus test in rodent tissues other than liver or erythrocytes: report of the IWGT working group","volume":"783","author":"Uno","year":"2015","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0200","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/978-1-62703-739-6_27","article-title":"ACB-PCR quantification of somatic oncomutation","volume":"1105","author":"Myers","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0205","series-title":"Detailed Review Paper on Transgenic Rodent Mutation Assays, Series on Testing and Assessment","author":"OECD","year":"2009"},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0210","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1365-2613.2009.00667.x","article-title":"Mutated K-ras(Asp12) promotes tumourigenesis in Apc(Min) mice more in the large than the small intestines, with synergistic effects between K-ras and Wnt pathways","volume":"90","author":"Luo","year":"2009","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0215","first-page":"w13112","article-title":"Kras in metastatic colorectal cancer","volume":"140","author":"Wicki","year":"2010","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0220","doi-asserted-by":"crossref","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resource","volume":"4","author":"Huang","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0225","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.yrtph.2012.05.019","article-title":"Assessment of genotoxic potential of Cr(VI) in the mouse duodenum: an in silico comparison with mutagenic and nonmutagenic carcinogens across tissues","volume":"64","author":"Thompson","year":"2012","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0230","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/0192623315611501","article-title":"Re-evaluation and classification of duodenal lesions in B6C3F1 Mice and F344 rats from four studies of hexavalent chromium in drinking water","volume":"44","author":"Cullen","year":"2016","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0235","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3109\/10408441003742903","article-title":"Carcinogenic mode of action of folpet in mice and evaluation of its relevance to humans","volume":"40","author":"Cohen","year":"2010","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0240","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/jat.1265","article-title":"Captan: transition from \u2018B2\u2019 to \u2018not likely'. how pesticide registrants affected the EPA cancer classification update","volume":"27","author":"Gordon","year":"2007","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0245","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1126\/science.2204108","article-title":"Cell proliferation in carcinogenesis","volume":"249","author":"Cohen","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0250","unstructured":"U.S. EPA, Captan; Cancer Reclassification; Amendment of ReregistrationEligibility Decision; Notice of Availability Federal Register 69 (2004) 68357\u201368360."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0255","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1006\/rtph.1997.1161","article-title":"Chloroform mode of action: implications for cancer risk assessment","volume":"26","author":"Golden","year":"1997","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0260","series-title":"Toxicological review of chloroform in support of summary information on the integrated risk information system (IRIS)","author":"U.S. EPA","year":"2001"},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0265","unstructured":"NTP, National Toxicology Program technical report on the toxicology and carcinogenesis studies of coconut oil acid diethanolamine condensate (CAS NO. 68603-42-9) in F344\/N rats and B6C3F1 mice (dermal studies), NIH Publication No. 01-3969 (2001)."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0270","unstructured":"MAK, The MAK Collection for Occupational Health and Safety (2015)."},{"key":"10.1016\/j.mrgentox.2016.01.008_bib0275","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.yrtph.2005.08.001","article-title":"Review of the carcinogenic activity of diethanolamine and evidence of choline deficiency as a plausible mode of action","volume":"43","author":"Leung","year":"2005","journal-title":"Regul. Toxicol. Pharmacol."}],"container-title":["Mutation Research\/Genetic Toxicology and Environmental Mutagenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383571815300334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383571815300334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T20:52:56Z","timestamp":1718398376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383571815300334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":55,"alternative-id":["S1383571815300334"],"URL":"https:\/\/doi.org\/10.1016\/j.mrgentox.2016.01.008","relation":{},"ISSN":["1383-5718"],"issn-type":[{"value":"1383-5718","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of in vivo genotoxic and carcinogenic potency to augment mode of action analysis: Case study with hexavalent chromium","name":"articletitle","label":"Article Title"},{"value":"Mutation Research\/Genetic Toxicology and Environmental Mutagenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mrgentox.2016.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}